| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |